Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Profound Medical (PROF) Enterprise Value (2023 - 2025)

Profound Medical has reported Enterprise Value over the past 3 years, most recently at -$59.7 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$59.7 million for Q4 2025, down 8.76% from a year ago — trailing twelve months through Dec 2025 was -$59.7 million (down 8.76% YoY), and the annual figure for FY2025 was -$59.7 million, down 8.76%.
  • Enterprise Value for Q4 2025 was -$59.7 million at Profound Medical, down from -$24.8 million in the prior quarter.
  • Over the last five years, Enterprise Value for PROF hit a ceiling of -$24.8 million in Q3 2025 and a floor of -$59.7 million in Q4 2025.
  • Median Enterprise Value over the past 3 years was -$40.8 million (2025), compared with a mean of -$41.2 million.
  • Biggest five-year swings in Enterprise Value: tumbled 109.48% in 2024 and later decreased 8.76% in 2025.
  • Profound Medical's Enterprise Value stood at -$26.2 million in 2023, then plummeted by 109.48% to -$54.9 million in 2024, then fell by 8.76% to -$59.7 million in 2025.
  • The last three reported values for Enterprise Value were -$59.7 million (Q4 2025), -$24.8 million (Q3 2025), and -$35.2 million (Q2 2025) per Business Quant data.